Tuesday, 29 August 2017

New trial alert: Management of malignant bowel obstruction (MBO) in patients with advanced gynecological cancers

A new trial, conducted at the Princess Margaret Cancer Centre in Toronto is seeking to optimize multidisciplinary care and evaluate treatment outcomes for malignant bowel obstruction (MBO) in women with advanced gynecological cancers.  According to the trial's hypothesis, "if patients with MBO can be effectively managed in an ambulatory setting, this may improve quality and consistency of patient care, and help reduce volume and duration of bed occupancy."

To read more about this trial, click here.

No comments:

Post a Comment